iFLYTEK Medical Technology's revenue in 2025 reached 915 million yuan, with a 31.1% growth in B-side business.

On March 27th, iFLYTEK Medical Technology released its annual performance report, achieving a revenue of 915 million yuan in 2025, a year-on-year increase of 24.7%; the net loss attributable to shareholders was 64.788 million yuan, a significant narrowing of the loss compared to the previous year. Among them, the revenue of hospital solutions business targeting the B-end was 173 million yuan, a year-on-year increase of 31.1%, accounting for 18.9% of the total revenue in 2025.